A new research report from Savita Subramanian and her well-regarded team at Merrill Lynch points out that some of the biggest positive surprises have been from the mega-cap stocks.
In a new report, the RBC team focused on the companies that are making the most progress with treatments for patients with breast cancer.
Credit Suisse has released a report that detailed its top picks for pharmaceutical stocks for the rest of 2015.
thinkstockMay 4, 2015: Markets opened higher on Monday after a relatively quiet night overseas. Both U.K. and Japanese equities markets were closed Monday for holidays. Other Asian and European markets closed higher…
thinkstockApril 28, 2015: Markets opened slightly higher on Tuesday but were able to cross back into positive territory on early strength from the tech and healthcare sectors. Equities appear headed for a…
Merck has managed to beat its first-quarter earnings expectations, and handily at that.
Jon C. Ogg thinkstockApril 27, 2015: Markets opened higher on Monday but there was little positive news to sustain the opening gains. Biotech stocks traded lower to drag the Nasdaq Composite lower. Heavyweight Apple reports…
Pharmaceutical giants Merck and Pfizer are both releasing their first quarter financial results early Tuesday.
24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average components reporting their financial results in the week ahead.
thinkstockApril 16, 2015: Markets opened lower on Thursday before climbing above the break-even line in the mid-afternoon. Crude oil futures rose to another year-to-date high today and three hot IPOs buoyed investors…
thinkstockApril 14, 2015: Markets opened higher on again on Tuesday but all three major indexes slipped below the breakeven line soon thereafter. The S&P 500 and the DJIA pulled back into positive…
The 30-year Treasury Bond yields only about 2.5% and, amazingly, more than half of the 30 Dow Jones Industrial Average stocks are yielding more than that.
SunTrust Robinson Humphrey analysts expect the pharmaceutical industry to outperform in 2015, driven in part by a solid new product cycle and an attractive five-year growth rate.
thinkstockMarch 18, 2015: Markets opened lower on Wednesday and bided its time below the break-even line until just after 2 p.m. and the FOMC’s announcement that it would no longer wait patiently…
A new research report from SunTrust Robinson Humphrey is very positive on pharmaceuticals, and the analysts expect the sector to outperform this year.
